Lonza Capacity Update October 2023: Small Molecule

Lonza is an industry-leading integrated CDMO to support your drug development from drug substances to finished drug products. With our world-class, global, high-quality facilities, we investigate new innovative ways to bring your molecule to life.

At Lonza’s facility in Bend (OR), our core capabilities include bioavailability enhancement, respiratory delivery, and multiparticulates. Our comprehensive offering extends beyond these core capabilities, encompassing material-sparing formulation development that continues seamlessly through the commercialization phase. Our early-phase clinical manufacturing facility provides agile, quick-to-clinic capabilities. The co-location of our expert formulators with our commercial manufacturing facility will ensure the success of your molecule.

The presentation will:

• Explore strategies for how to overcome your bioavailability enhancement challenges
• Discuss the respiratory delivery expertise of the Bend Inhalation Group
• Demonstrate how our experts can help you to formulate multiparticulates that align with your project goals.